Table 4.
Independent variable | N countries | OR | 95% CI | p-value |
---|---|---|---|---|
A. Screening coveragea | ||||
Income level | <0.001 | |||
High | 12 | Ref | Ref | |
Upper-middle | 20 | 0.58 | 0.38–0.89 | |
Lower-middle | 4 | 0.52 | 0.25–1.07 | |
Low | 1 | 0.05 | 0.01–0.29 | |
Predominant health system type | 0.02 | |||
No-fragmented (NHS/NHI) | 19 | Ref | Ref | |
Fragmented (SS/OP) | 18 | 0.59 | 0.39–0.90 | |
Independent variable | N countries | RR | 95%CI | p-value |
B. Cervical cancer mortalityb | ||||
Screen and treat approach | 0.03 | |||
No/no program | 18 | Ref | Ref | |
Yes | 12 | 1.38 | 1.03–1.84 | |
Missing | 1 | – | – | |
Inequality-adjusted HDI | 0.01 | |||
Very high/High | 5 | Ref | Ref | |
Medium | 7 | 1.92 | 1.24–3.10 | |
Low | 4 | 1.91 | 1.15–3.27 | |
Missing | 5 | – | – |
OR: Odds Ratio, RR: Rate Ratio, CI: Confidence Interval, NHS: National Health system, NHI: National Health Insurance, SS: Social Security, OP: Out of pocket, HDI: Human Development Index. Data in bold correspond to statistically significant associations.
Beta-regression model.
Poisson-regression model. Coverage for women aged 25–65 years, 3-years interval. For cervical cancer mortality screening coverage is included as an independent variable and missing categories are not included in the regression models.